US Broker Ratings

The Ensign Group, Inc. (ENSG) Stock Analysis: Eyeing a 30.73% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specializing in medical care facilities across the United States. With a market capitalization of $9.85..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with a 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, boasting a robust market capitalization of $123.19 billion. Known for its transformative therapies targeting serious diseases,..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: A Healthcare Innovator with a 5.57% Upside Potential

Glaukos Corporation (NYSE: GKOS), a prominent player in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its innovative products and promising financial outlook...

Ionis Pharmaceuticals (IONS): Analyst Consensus Reveals 60% Upside Potential for This Biotech Innovator

For investors with an eye on the biotechnology sector, Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) presents a compelling opportunity. As a commercial-stage biotechnology company headquartered in Carlsbad, California, Ionis is at..

Guardant Health, Inc. (GH) Stock Analysis: Navigating High Growth in the Precision Oncology Market

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, has been capturing investor attention with its innovative solutions in cancer diagnostics and research. Headquartered in Palo Alto, California, the..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a Market Leader’s Potential Amidst Healthcare Innovation

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, stands as a compelling consideration for investors seeking exposure to the drug manufacturing industry. With a robust market capitalization of..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 37.52% Potential Upside in the Medical Devices Sector

As the healthcare sector continues its dynamic expansion, Globus Medical, Inc. (NYSE: GMED) stands out in the medical devices industry with a compelling investment case. With a market capitalization of..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 19.64% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline and impressive market performance. Based in the Netherlands, argenx is..

Fresenius Medical Care AG (FMS) Stock Analysis: Insights into a 3.63% Dividend Yield and Growth Potential

Investors interested in the healthcare sector, particularly in medical care facilities, should pay close attention to Fresenius Medical Care AG (FMS). As a global leader in dialysis services and products,..

Agilent Technologies, Inc. (A) Stock Analysis: Is There a Potential 18.56% Upside for Investors?

Agilent Technologies, Inc. (NYSE: A), a formidable player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors with its projected 18.56% potential..

Qiagen N.V. (QGEN) Stock Analysis: Healthcare Innovator with a Promising 7.11% Upside

Qiagen N.V. (NYSE: QGEN), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is making headlines with its innovative approaches to transforming biological samples into..

Genmab A/S (GMAB) Stock Analysis: Unlocking a 26.68% Upside with Strong Buy Ratings

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) represents a compelling case with a significant potential upside. The Danish biotech company, boasting a market capitalization of..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 19.74% Potential Upside Amidst Market Volatility

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector and a key player in the drug manufacturing industry, presents a fascinating opportunity for investors seeking both income and growth...

The Cooper Companies, Inc. (COO) Investor Outlook: A 14.67% Upside Potential Amid Healthcare Growth

Investors looking for opportunities in the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing prospect, with analysts projecting a potential upside of 14.67%. This American medical..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth and Valuation Amidst Healthcare Sector Trends

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking both innovation and stability. Headquartered in Billerica, Massachusetts,..

Veeva Systems Inc. (VEEV) Investor Outlook: Unpacking the 28.65% Potential Upside

Veeva Systems Inc. (NYSE: VEEV), a stalwart in the healthcare sector, offers a compelling investment narrative with a potential upside of 28.65%, as indicated by analyst price targets. Specializing in..

Waters Corporation (WAT) Stock Analysis: A Healthcare Leader with an 8.15% Upside Potential

Waters Corporation (NYSE: WAT) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a robust market cap of $36.96 billion, Waters continues..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unveiling a 10% Upside Potential in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its innovative approach to drug delivery. With a market capitalization of $9.04 billion, Halozyme has positioned itself..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating a Challenging Market Landscape

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a promising player in the healthcare sector with a focus on Traditional Chinese Medicine (TCM), offers a unique proposition with its specialization in neurocognitive..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds